enVVeno Medical NVNO
NASDAQ NVNO
$10.62 +0.14 (+1.31%)
At close: Aug 20, 2026 · 1:10 PM UTC

enVVeno Medical (NVNO) Non-Current Debt (2017)

enVVeno Medical (NVNO) posted quarterly Non-Current Debt of $275000.0 for Q4 2017.

enVVeno Medical (NVNO) Non-Current Debt (2017) Analysis & Trends

enVVeno Medical's Non-Current Debt history runs 1 years deep, the most recent figure standing at $275000.0 for Q4 2017.

  • In Q4 2017, Non-Current Debt changed N/A year-over-year to $275000.0; the TTM figure through Dec 2017 stood at $275000.0 (changed N/A YoY), while the FY2017 annual figure was $275000.0, changed N/A from the prior year.
  • Non-Current Debt for Q4 2017 stood at $275000.0.
  • The five-year high for Non-Current Debt was $275000.0 in Q4 2017, with the low at $275000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Abbott Laboratories 199.12 Bn 193.52 Bn 7.27 Bn 29.60 Bn
2 Stryker 128.79 Bn 125.32 Bn 4.50 Bn 14.19 Bn
3 Medtronic 119.30 Bn 110.08 Bn 6.41 Bn 26.17 Bn
4 Boston Scientific 73.50 Bn 72.96 Bn 3.85 Bn 10.92 Bn
5 Edwards Lifesciences 52.11 Bn 47.86 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.62 Bn 32.67 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.05 Bn 31.94 Bn 2.18 Bn 10.09 Bn
8 Koninklijke Philips 26.42 Bn 23.10 Bn 4.55 Bn 7.34 Bn
9 Steris 23.15 Bn 22.67 Bn 684.20 Mn 1.65 Bn
10 enVVeno Medical 6.92 Mn 6.92 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 275,000.00